SLCO2A1 and breast cancer: Among the enriched KEGG pathways, Paclitaxel inhibits the proliferation and invasion of the MCF-7 cell in PI3K-AKT signaling pathway (Associated KGs: ANGPT1, SLCO2A1 and BCL11A) to prevent BC [57].